Cite
HARVARD Citation
Kadia, T. et al. (2021). Venetoclax plus intensive chemotherapy with cladribine, idarubicin, and cytarabine in patients with newly diagnosed acute myeloid leukaemia or high-risk myelodysplastic syndrome: a cohort from a single-centre, single-arm, phase 2 trial. Lancet. 8 (8), pp. e552-e561. [Online].